Walleye Capital LLC Alkermes Plc. Transaction History

Walleye Capital LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$23.21 - $27.24 $61,715 - $72,431	2,659 Added 7.45%	38,372 $924,000
Q1 2024 May 15, 2024	BUY	$26.4 - $32.56 $942,823 - $1.16 Million	35,713 New	35,713 $966,000
Q3 2023 Nov 14, 2023	BUY	$27.17 - $31.97 $173,263 - $203,872	6,377 New	6,377 $178,000
Q2 2022 Aug 08, 2022	BUY	$26.4 - $30.54 $2.28 Million - $2.64 Million	86,344 New	86,344 $2.57 Million
Q1 2020 May 15, 2020	SELL	$13.06 - $21.24 $244,979 - $398,419	-18,758 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$17.29 - $21.74 $324,325 - $407,798	18,758 New	18,758 $382,000
Q3 2019 Nov 14, 2019	SELL	$19.51 - $24.28 $278,836 - $347,009	-14,292 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$21.47 - $37.33 $241,258 - $419,477	11,237 Added 367.82%	14,292 $322,000
Q1 2019 May 15, 2019	BUY	$28.4 - $36.49 $86,762 - $111,476	3,055 New	3,055 $111,000

361

181M

175K

96.6K

Ticker ALKS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 164,254,000
Market Cap $4.73B
Description
Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...

Get notified when there are updates to the investment portfolio of Walleye Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Walleye Capital LLC with notifications on news.